Aptevo Therapeutics Inc. (APVO)
NASDAQ·Healthcare·Biotechnology
$3.96
-5.94%
Mkt Cap $10.82M
No analyst coverage available
We don't have analyst ratings or price target data for Aptevo Therapeutics Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.